| - GRCh37:
- Chr11:20101020-34485543
- GRCh38:
- Chr11:20079474-34463996
| ABTB2, ANO3, ANO3-AS1, ANO5, ARL14EP, ARL14EP-DT, BBOX1, BBOX1-AS1, BDNF, BDNF-AS, C11orf91, CAPRIN1, CAT, CCDC179, CCDC34, CCDC73, CD59, CSTF3, CSTF3-DT, DBX1, DCDC1, DEPDC7, DNAJC24, EIF3M, ELP4, FANCF, FBXO3, FBXO3-DT, FIBIN, FSHB, GAS2, HIPK3, HTATIP2, IMMP1L, KCNA4, KIAA1549L, KIF18A, LGR4, LGR4-AS1, LIN7C, LINC00294, LINC00678, LINC01495, LINC01616, LINC02546, LINC02686, LINC02699, LINC02718, LINC02721, LINC02722, LINC02726, LINC02742, LINC02755, LINC02758, LINC02859, LINC03031, LMO2, LOC101928385, LOC105980003, LOC105980005, LOC105980073, LOC106007485, LOC106007493, LOC106014249, LOC106707172, LOC106707173, LOC107982234, LOC108178983, LOC108178984, LOC110120941, LOC110121388, LOC110121452, LOC111365162, LOC112067717, LOC112067718, LOC113939921, LOC116216130, LOC116216131, LOC116216132, LOC116216133, LOC121832789, LOC124421507, LOC124421508, LOC124421509, LOC124421510, LOC124421511, LOC124421512, LOC124421513, LOC124421514, LOC124421515, LOC124421516, LOC124421517, LOC124433243, LOC126861159, LOC126861160, LOC126861161, LOC126861162, LOC126861163, LOC126861164, LOC126861165, LOC126861166, LOC126861167, LOC126861168, LOC126861169, LOC126861170, LOC126861171, LOC126861172, LOC126861173, LOC126861174, LOC126861175, LOC126861176, LOC126861177, LOC126861178, LOC126861179, LOC126861180, LUZP2, METTL15, MIR610, MIR8054, MIR8068, MIR8087, MPPED2, MPPED2-AS1, MUC15, NAT10, NAV2, NELL1, PAUPAR, PAX6, PAX6-AS1, PAX6DRR, PAX6_HS2, PAX6_HS3, PAX6_HS8, PRMT3, PRRG4, QSER1, RCN1, SLC17A6, SLC5A12, SLC6A5, SNORA88, SVIP, TCP11L1, WT1, WT1-AS | | See cases | Pathogenic (Aug 30, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr11:22571661-38220709
- GRCh38:
- Chr11:22550115-38199159
| ABTB2, ANO3, ANO3-AS1, APIP, ARL14EP, ARL14EP-DT, BBOX1, BBOX1-AS1, BDNF, BDNF-AS, C11orf91, CAPRIN1, CAT, CCDC179, CCDC34, CCDC73, CD44, CD44-AS1, CD44-DT, CD59, COMMD9, CSTF3, CSTF3-DT, DCDC1, DEPDC7, DNAJC24, EHF, EIF3M, ELF5, ELP4, FANCF, FBXO3, FBXO3-DT, FIBIN, FJX1, FSHB, GAS2, HIPK3, IFTAP, IMMP1L, KCNA4, KIAA1549L, KIF18A, LDLRAD3, LGR4, LGR4-AS1, LIN7C, LINC00294, LINC00678, LINC01616, LINC02546, LINC02686, LINC02699, LINC02707, LINC02718, LINC02721, LINC02722, LINC02726, LINC02742, LINC02755, LINC02758, LINC02760, LINC02859, LINC03031, LMO2, LOC101928385, LOC101928510, LOC105980003, LOC105980005, LOC105980073, LOC106007485, LOC106007493, LOC106014249, LOC106707172, LOC106707173, LOC107982234, LOC108178983, LOC108178984, LOC110120941, LOC110121388, LOC110121452, LOC112067717, LOC112067718, LOC112081392, LOC112081393, LOC113939921, LOC116216130, LOC116216131, LOC116216132, LOC116216133, LOC116216134, LOC121392907, LOC121392908, LOC121832789, LOC121832790, LOC124421508, LOC124421509, LOC124421510, LOC124421511, LOC124421512, LOC124421513, LOC124421514, LOC124421515, LOC124421516, LOC124421517, LOC124433243, LOC124433244, LOC124433245, LOC124433246, LOC124433247, LOC126861162, LOC126861163, LOC126861164, LOC126861165, LOC126861166, LOC126861167, LOC126861168, LOC126861169, LOC126861170, LOC126861171, LOC126861172, LOC126861173, LOC126861174, LOC126861175, LOC126861176, LOC126861177, LOC126861178, LOC126861179, LOC126861180, LOC126861181, LOC126861182, LOC126861183, LOC126861184, LOC126861185, LOC126861186, LOC126861187, LOC126861188, LOC126861189, LOC126861190, LOC126861191, LOC126861192, LOC126861193, LUZP2, METTL15, MIR1343, MIR3973, MIR610, MIR8054, MIR8068, MIR8087, MPPED2, MPPED2-AS1, MUC15, NAT10, PAMR1, PAUPAR, PAX6, PAX6-AS1, PAX6DRR, PAX6_HS2, PAX6_HS3, PAX6_HS8, PDHX, PRR5L, PRRG4, QSER1, RAG1, RAG2, RCN1, SLC1A2, SLC5A12, SNORA88, SNORD164, SVIP, TCP11L1, TRAF6, TRIM44, WT1, WT1-AS | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr11:26390509-35274523
- GRCh38:
- Chr11:26368962-35252976
| ABTB2, ANO3, APIP, ARL14EP, ARL14EP-DT, BBOX1, BBOX1-AS1, BDNF, BDNF-AS, C11orf91, CAPRIN1, CAT, CCDC34, CCDC73, CD44, CD44-AS1, CD44-DT, CD59, CSTF3, CSTF3-DT, DCDC1, DEPDC7, DNAJC24, EHF, EIF3M, ELF5, ELP4, FBXO3, FBXO3-DT, FIBIN, FSHB, HIPK3, IMMP1L, KCNA4, KIAA1549L, KIF18A, LGR4, LGR4-AS1, LIN7C, LINC00294, LINC00678, LINC01616, LINC02546, LINC02707, LINC02721, LINC02722, LINC02742, LINC02755, LINC02758, LINC02859, LINC03031, LMO2, LOC101928385, LOC105980003, LOC105980005, LOC105980073, LOC106007485, LOC106007493, LOC106014249, LOC106707172, LOC106707173, LOC107982234, LOC108178983, LOC108178984, LOC110120941, LOC110121388, LOC110121452, LOC112067717, LOC112067718, LOC112081392, LOC112081393, LOC116216130, LOC116216131, LOC116216132, LOC116216133, LOC116216134, LOC121392907, LOC124421509, LOC124421510, LOC124421511, LOC124421512, LOC124421513, LOC124421514, LOC124421515, LOC124421516, LOC124421517, LOC124433243, LOC124433244, LOC126861169, LOC126861170, LOC126861171, LOC126861172, LOC126861173, LOC126861174, LOC126861175, LOC126861176, LOC126861177, LOC126861178, LOC126861179, LOC126861180, LOC126861181, LOC126861182, LOC126861183, LOC126861184, LOC126861185, LOC126861186, METTL15, MIR1343, MIR610, MIR8068, MIR8087, MPPED2, MPPED2-AS1, MUC15, NAT10, PAUPAR, PAX6, PAX6-AS1, PAX6DRR, PAX6_HS2, PAX6_HS3, PAX6_HS8, PDHX, PRRG4, QSER1, RCN1, SLC1A2, SLC5A12, SNORA88, SNORD164, TCP11L1, WT1, WT1-AS | | See cases | Pathogenic (Nov 30, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr11:32409365
- GRCh38:
- Chr11:32387819
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409379
- GRCh38:
- Chr11:32387833
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409395
- GRCh38:
- Chr11:32387849
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Benign/Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409437
- GRCh38:
- Chr11:32387891
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409472
- GRCh38:
- Chr11:32387926
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409506
- GRCh38:
- Chr11:32387960
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Benign/Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409538
- GRCh38:
- Chr11:32387992
| WT1 | | Wilms tumor 1, Meacham syndrome, Nephrotic syndrome, type 4
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409546
- GRCh38:
- Chr11:32388000
| WT1 | | 11p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4, Meacham syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409549-32409550
- GRCh38:
- Chr11:32388003-32388004
| WT1 | | Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome, Meacham syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409549-32409550
- GRCh38:
- Chr11:32388003-32388004
| WT1 | | 11p partial monosomy syndrome, Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409549-32409550
- GRCh38:
- Chr11:32388003-32388004
| WT1 | | 11p partial monosomy syndrome, Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409550-32409555
- GRCh38:
- Chr11:32388004-32388009
| WT1 | | Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome, Meacham syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409550-32409553
- GRCh38:
- Chr11:32388004-32388007
| WT1 | | Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409555
- GRCh38:
- Chr11:32388009
| WT1 | | Nephrotic syndrome, type 4, Nephroblastoma, Meacham syndrome
| Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409625-32409626
- GRCh38:
- Chr11:32388079-32388080
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Nephroblastoma
| Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409701
- GRCh38:
- Chr11:32388155
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Benign/Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409707
- GRCh38:
- Chr11:32388161
| WT1 | | Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome, Meacham syndrome | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409740
- GRCh38:
- Chr11:32388194
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Benign/Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409740
- GRCh38:
- Chr11:32388194
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409763
- GRCh38:
- Chr11:32388217
| WT1 | | 11p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4, Meacham syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409769
- GRCh38:
- Chr11:32388223
| WT1 | | Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
| Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409784
- GRCh38:
- Chr11:32388238
| WT1 | | Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
| Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409819
- GRCh38:
- Chr11:32388273
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409836
- GRCh38:
- Chr11:32388290
| WT1 | | 11p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4, Meacham syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409863
- GRCh38:
- Chr11:32388317
| WT1 | | 11p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4, Meacham syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409897
- GRCh38:
- Chr11:32388351
| WT1 | | Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409919
- GRCh38:
- Chr11:32388373
| WT1 | | Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409938
- GRCh38:
- Chr11:32388392
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409975
- GRCh38:
- Chr11:32388429
| WT1 | | Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409990
- GRCh38:
- Chr11:32388444
| WT1 | | Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32409993
- GRCh38:
- Chr11:32388447
| WT1 | | Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410002
- GRCh38:
- Chr11:32388456
| WT1 | | Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
| Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410030
- GRCh38:
- Chr11:32388484
| WT1 | | Meacham syndrome, Nephrotic syndrome, type 4, Nephroblastoma, 11p partial monosomy syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410062
- GRCh38:
- Chr11:32388516
| WT1 | | Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410070
- GRCh38:
- Chr11:32388524
| WT1 | | Wilms tumor 1, Nephrotic syndrome, type 4, Meacham syndrome
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410091
- GRCh38:
- Chr11:32388545
| WT1 | | Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410144
- GRCh38:
- Chr11:32388598
| WT1 | | Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410211
- GRCh38:
- Chr11:32388665
| WT1 | | Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410238
- GRCh38:
- Chr11:32388692
| WT1 | | 11p partial monosomy syndrome, Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410250
- GRCh38:
- Chr11:32388704
| WT1 | | 11p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4, Meacham syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410259
- GRCh38:
- Chr11:32388713
| WT1 | | Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
| Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410335
- GRCh38:
- Chr11:32388789
| WT1 | | 11p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4, Meacham syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410337
- GRCh38:
- Chr11:32388791
| WT1 | | not provided, Meacham syndrome, Nephrotic syndrome, type 4, Frasier syndrome, Drash syndrome, Wilms tumor 1
| Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410365
- GRCh38:
- Chr11:32388819
| WT1 | | Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410380
- GRCh38:
- Chr11:32388834
| WT1 | | not provided, Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4, Frasier syndrome, Drash syndrome
| Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410445
- GRCh38:
- Chr11:32388899
| WT1 | | Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410466
- GRCh38:
- Chr11:32388920
| WT1 | | 11p partial monosomy syndrome, Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4 | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410494
- GRCh38:
- Chr11:32388948
| WT1 | | Meacham syndrome, Nephrotic syndrome, type 4, Wilms tumor 1
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410504
- GRCh38:
- Chr11:32388958
| WT1 | | Wilms tumor 1, Meacham syndrome, Nephrotic syndrome, type 4
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410516
- GRCh38:
- Chr11:32388970
| WT1 | | not provided, Wilms tumor 1, Meacham syndrome, Frasier syndrome, Nephrotic syndrome, type 4, Drash syndrome
| Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410588
- GRCh38:
- Chr11:32389042
| WT1 | | not provided, Wilms tumor 1, Meacham syndrome, Drash syndrome, Nephrotic syndrome, type 4, Frasier syndrome
| Benign/Likely benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410592
- GRCh38:
- Chr11:32389046
| WT1 | | Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
| Conflicting interpretations of pathogenicity (Jan 12, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:32410594-32456901
- GRCh38:
- Chr11:32389048-32435355
| LOC106707172, LOC107982234, WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Pathogenic (Sep 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410594-32421600
- GRCh38:
- Chr11:32389048-32400054
| WT1 | | Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome, Frasier syndrome | Uncertain significance (Dec 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410599
- GRCh38:
- Chr11:32389053
| WT1 | | Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410604
- GRCh38:
- Chr11:32389058
| WT1 | | Frasier syndrome, Drash syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410604-32456891
- GRCh38:
- Chr11:32389058-32435345
| LOC106707172, LOC107982234, WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Pathogenic (Sep 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410605
- GRCh38:
- Chr11:32389059
| WT1 | | Kidney disorder, Wilms tumor 1, Meacham syndrome, Nephrotic syndrome, type 4, Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome, not provided
| Conflicting interpretations of pathogenicity (Sep 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:32410610
- GRCh38:
- Chr11:32389064
| WT1 | | Drash syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome | Likely benign (Nov 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410610
- GRCh38:
- Chr11:32389064
| WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410611
- GRCh38:
- Chr11:32389065
| WT1 | A125V, A287V, A301V, A518V, A521V, A501V, A463V, A490V, A504V, A474V, A477V, A499V, A516V, A267V, A473V | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4, Drash syndrome, Frasier syndrome, Wilms tumor 1, Meacham syndrome, Mesothelioma, malignant11p partial monosomy syndrome, not provided, ...see more | Uncertain significance (Dec 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410612
- GRCh38:
- Chr11:32389066
| WT1 | A125P, A301P, A287P, A501P, A518P, A521P, A473P, A490P, A504P, A516P, A267P, A474P, A499P, A463P, A477P | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410614
- GRCh38:
- Chr11:32389068
| WT1 | L517P, L300P, L520P, L124P, L286P, L500P, L266P, L473P, L515P, L472P, L503P, L489P, L462P, L476P, L498P | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Inborn genetic diseases, Meacham syndrome, Mesothelioma, malignant, Aniridia 1, Drash syndrome, Nephrotic syndrome, type 4, Frasier syndromeWilms tumor 1, 11p partial monosomy syndrome, ...see more | Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410616
- GRCh38:
- Chr11:32389070
| WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Likely benign (Mar 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410618
- GRCh38:
- Chr11:32389072
| WT1 | Q285*, Q499*, Q123*, Q519*, Q299*, Q516*, Q265*, Q471*, Q497*, Q514*, Q461*, Q472*, Q502*, Q475*, Q488* | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410619
- GRCh38:
- Chr11:32389073
| WT1 | | Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome, Drash syndrome | Likely benign (Feb 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410628
- GRCh38:
- Chr11:32389082
| WT1 | M281I, M515I, M295I, M495I, M512I, M119I, M498I, M493I, M510I, M261I, M457I, M467I, M484I, M468I, M471I | Drash syndrome, Wilms tumor 1, Frasier syndrome, 11p partial monosomy syndrome | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410632
- GRCh38:
- Chr11:32389086
| WT1 | N294T, N456T, N467T, N509T, N511T, N466T, N470T, N492T, N497T, N118T, N494T, N260T, N280T, N483T, N514T | Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome, Drash syndrome | Uncertain significance (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410632
- GRCh38:
- Chr11:32389086
| WT1 | N294S, N514S, N280S, N494S, N118S, N511S, N467S, N470S, N466S, N483S, N497S, N260S, N456S, N492S | Drash syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome, Drash syndrome, Wilms tumor 1
| Uncertain significance (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410632
- GRCh38:
- Chr11:32389086
| WT1 | N294I, N514I, N118I, N511I, N280I, N494I, N483I, N467I, N260I, N466I, N492I, N497I, N456I, N470I | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410635
- GRCh38:
- Chr11:32389089
| WT1 | R293T, R513T, R117T, R279T, R510T, R493T, R496T, R259T, R455T, R469T, R482T, R465T, R466T, R491T | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410639
- GRCh38:
- Chr11:32389093
| WT1 | Q116*, Q278*, Q292*, Q492*, Q509*, Q512*, Q464*, Q454*, Q465*, Q490*, Q495*, Q507*, Q258*, Q468*, Q481* | Nephrotic syndrome, type 4 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410644
- GRCh38:
- Chr11:32389098
| WT1 | M114K, M276K, M290K, M490K, M507K, M510K, M463K, M466K, M479K, M493K, M256K, M452K, M462K, M505K, M488K | Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome, Drash syndrome | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410645
- GRCh38:
- Chr11:32389099
| WT1 | M510V, M290V, M276V, M114V, M507V, M490V, M452V, M462V, M463V, M488V, M493V, M466V, M256V, M479V | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Oct 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410647
- GRCh38:
- Chr11:32389101
| WT1 | N275I, N289I, N506I, N489I, N509I, N113I, N451I, N461I, N504I, N255I, N465I, N492I, N462I, N478I, N487I | Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410649
- GRCh38:
- Chr11:32389103
| WT1 | H288Q, H508Q, H488Q, H505Q, H112Q, H274Q, H450Q, H254Q, H460Q, H464Q, H477Q, H486Q, H491Q, H461Q | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410656
- GRCh38:
- Chr11:32389110
| WT1 | R272L, R110L, R486L, R503L, R286L, R506L, R252L, R458L, R475L, R484L, R489L, R501L, R448L, R459L, R462L | Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410657
- GRCh38:
- Chr11:32389111
| WT1 | R272C, R475C, R503C, R110C, R462C, R252C, R448C, R486C, R489C, R286C, R458C, R459C, R484C, R501C, R506C | Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome, Drash syndrome | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410658
- GRCh38:
- Chr11:32389112
| WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Likely benign (Aug 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410660
- GRCh38:
- Chr11:32389114
| WT1 | V109L, V271L, V285L, V502L, V505L, V485L, V457L, V458L, V461L, V500L, V474L, V251L, V483L, V488L, V447L | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410663
- GRCh38:
- Chr11:32389117
| WT1 | L456V, L457V, L487V, L270V, L473V, L499V, L504V, L108V, L250V, L446V, L482V, L501V, L284V, L460V, L484V | Wilms tumor 1, Drash syndrome, 11p partial monosomy syndrome, Frasier syndrome | Uncertain significance (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410673
- GRCh38:
- Chr11:32389127
| WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Likely benign (Jul 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410674
- GRCh38:
- Chr11:32389128
| WT1 | R480Q, R497Q, R280Q, R104Q, R266Q, R500Q, R442Q, R483Q, R495Q, R452Q, R453Q, R456Q, R469Q, R246Q, R478Q | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Pathogenic (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410675
- GRCh38:
- Chr11:32389129
| WT1 | R104W, R246W, R266W, R280W, R442W, R452W, R453W, R456W, R469W, R478W, R480W, R483W, R495W, R497W, R500W | WT1-related disorder | Likely pathogenic (Feb 7, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410677
- GRCh38:
- Chr11:32389131
| WT1 | A103G, A279G, A479G, A496G, A499G, A265G, A452G, A482G, A451G, A477G, A441G, A494G, A245G, A455G, A468G | Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome | Uncertain significance (Nov 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410686
- GRCh38:
- Chr11:32389140
| WT1 | K476R, K496R, K262R, K493R, K100R, K276R, K438R, K452R, K448R, K449R, K242R, K479R, K465R, K474R, K491R | Aniridia 1, Meacham syndrome, Mesothelioma, malignant, Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome, Nephrotic syndrome, type 4, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Drash syndromeFrasier syndrome, ...see more | Uncertain significance (Oct 22, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410688
- GRCh38:
- Chr11:32389142
| WT1 | Q261H, Q275H, Q437H, Q464H, Q473H, Q475H, Q490H, Q495H, Q241H, Q451H, Q99H, Q447H, Q492H, Q448H, Q478H | Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome, Drash syndrome | Uncertain significance (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410694
- GRCh38:
- Chr11:32389148
| WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Likely benign (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410695
- GRCh38:
- Chr11:32389149
| WT1 | S273N, S493N, S259N, S490N, S97N, S473N, S239N, S446N, S449N, S435N, S462N, S471N, S445N, S476N | Wilms tumor 1, Frasier syndrome, Wilms tumor 1, Drash syndrome, 11p partial monosomy syndrome, Frasier syndrome
| Uncertain significance (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410696
- GRCh38:
- Chr11:32389150
| WT1 | S493G, S97G, S473G, S490G, S259G, S273G, S449G, S471G, S476G, S488G, S239G, S445G, S446G, S462G, S435G | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome, Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:32410696
- GRCh38:
- Chr11:32389150
| WT1 | S273R, S473R, S493R, S259R, S490R, S97R, S471R, S476R, S239R, S435R, S446R, S445R, S462R, S449R, S488R | Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome, Frasier syndrome | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410697
- GRCh38:
- Chr11:32389151
| WT1 | | Drash syndrome, Wilms tumor 1, Frasier syndrome, 11p partial monosomy syndrome | Likely benign (Oct 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410699
- GRCh38:
- Chr11:32389153
| WT1 | P272S, P492S, P489S, P258S, P472S, P96S, P444S, P434S, P448S, P475S, P470S, P238S, P445S, P461S | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410704
- GRCh38:
- Chr11:32389158
| WT1 | R270Q, R490Q, R256Q, R470Q, R487Q, R94Q, R446Q, R459Q, R236Q, R442Q, R443Q, R468Q, R473Q, R432Q | Frasier syndrome, Drash syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410705
- GRCh38:
- Chr11:32389159
| WT1 | R270W, R490W, R487W, R94W, R256W, R470W, R459W, R432W, R443W, R442W, R446W, R236W, R468W, R473W | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410706
- GRCh38:
- Chr11:32389160
| WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Likely benign (Sep 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:32410709
- GRCh38:
- Chr11:32389163
| WT1 | | Drash syndrome, Frasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome | Likely benign (Jun 4, 2018) | criteria provided, single submitter |